Knowledge Base - Massachusetts Biotechnology Council - Massachusetts Biotechnology Council

Hogan Lovells: Life Sciences and Health Care Horizons 2019 Hogan Lovells March 22, 2019

In the 2019 edition of our Life Sciences and Health Care Horizons publication, our global team identifies a number of current and evolving trends that are shaping the future of the industry. Read More

Situation Analysis and Opportunity Assessment New Perspectives, Inc. March 11, 2019

A successful product development strategy requires a comprehensive understanding of the market environment. Learn more… Read More

Conducting Feasibility for a New Clinical Trial April 10, 2018 in White Papers,

What does the word “feasibility” mean to you? It may seem like a simple question, but I have found that “feasibility” has many interpretations within the clinical research industry. When we work with Read More

Not Just Tiny Humans: Considerations for Conducting Pediatric Clinical Trials April 3, 2018 in White Papers,

When it comes to the conduct of pediatric clinical trials, there are number of things you need to consider in order to ensure the successful conduct of a study. While we can’t predict the outcome, pla Read More

President Trump and the Big 6 Tax Plan: What Can We Expect? WithumSmith+Brown November 1, 2017 in Advisories,

Earlier this week, President Trump and the “Big 6” Republican leaders announced their long-awaited tax plan, setting the following goals for the proposal. Read More

Clinical Trials in Australia: Industry Capability Report Australian Trade and Investment Commission August 9, 2017 in White Papers,

Australia is regarded as one of the best places in the world to conduct clinical trials. Download the report for case studies with leading pharma companies to learn why. Read More

Business success in the life sciences: an investment banker’s perspective Outcome Capital June 28, 2017 in White Papers,

As we are passionate about bringing paradigm-shifting technologies to patients, we were excited by the opportunity to facilitate transatlantic collaborations between Boston’s biotech hub and the life Read More

Platforms versus products in the life sciences sector Outcome Capital June 23, 2017

In an expert view piece, Dr Oded Ben-Joseph and Dr Shawn Manning, from investment bank Outcome Capital, advise on how life sciences companies can curtail risk by allocating time and money in a capital Read More

FREE WEBINAR: Communicating innovation to payers and policy makers Cello Health November 23, 2016 in Presentation & Video Library,

Involving public affairs early during the development and commercialization process of a new asset is critical to success when demonstrating value to payers and policy makers. Learn how to communicate value during this... Read More